Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.
about
Modelling clinical systemic lupus erythematosus: similarities, differences and success storiesAntibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationMycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.A pilot study to examine the effect of chronic treatment with immunosuppressive drugs on mucociliary clearance in a vagotomized murine modelTherapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 miceBcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.Mycophenolate mofetil in lupus nephritis.Mycophenolate mofetil in animal models of autoimmune disease.Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertensionImmune and inflammatory role in renal disease.Mycophenolate mofetil in the treatment of lupus nephritis.New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic.Treatment of severe lupus nephritis: the new horizon.Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune DiseaseMycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.Mycophenolate mofetil and animal models
P2860
Q28074217-4CD67977-C4D0-4CD9-B5B0-B35216625398Q28076193-4369ECC4-F5ED-489E-9713-B584961ADF0DQ33377162-C74B90F3-A32B-480A-9FC2-3637EBF421F7Q34392717-6091D1DD-9E8A-4A4D-A8B6-9860CDF482D2Q34428705-CFB183F8-020D-4F8C-866F-69FE9DA47A18Q34896306-37D5F663-0932-440E-9604-82F4F285DEF0Q36012345-67FCB74C-E5C4-43F7-81D2-6FFC3F524A28Q36054863-85331E0B-A5B8-4E72-9FE0-492A8AA9F2A5Q36085848-9A4974EF-DF99-45A8-92C0-99258BD6CF43Q36733468-C32C266A-0933-4E75-BDCB-4E978CFC2C9CQ36844520-FE2BBC71-0CB3-446F-87BE-DB079843B05BQ37243199-AC1E990F-39D9-4A54-B043-F86C09408E19Q37290624-CF252B23-DDCE-4C3A-96E4-F26AB2E185D6Q38148585-AEF3167B-B49B-41BC-9B4B-74471E1525EBQ38271125-E15F7C63-F6D8-432C-882A-BAB10B625D8CQ38938727-A946FB80-D0CC-4FA6-9BB4-E54A5DAE1363Q44766216-C1218C93-EFD3-4877-844D-A03E4FFBD924Q46815725-2453C778-3B1F-4862-91DF-C7CA15F4E55CQ57839861-54CBAF53-7A7A-498D-BC70-31A4E8FFA988
P2860
Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Modulation of autoantibody pro ...... of SLE in (NZB x NZW)F1 mice.
@en
Modulation of autoantibody pro ...... s on the development of SLE in
@nl
type
label
Modulation of autoantibody pro ...... of SLE in (NZB x NZW)F1 mice.
@en
Modulation of autoantibody pro ...... s on the development of SLE in
@nl
prefLabel
Modulation of autoantibody pro ...... of SLE in (NZB x NZW)F1 mice.
@en
Modulation of autoantibody pro ...... s on the development of SLE in
@nl
P2093
P2860
P356
P1476
Modulation of autoantibody pro ...... t of SLE in (NZB x NZW)F1 mice
@en
P2093
Angel-Luis M de Francisco
Celestino Piñera
Luis Buelta
Manuel Arias
Maria Angeles Ramos
Maria Angeles Setién
Maria Angeles de Cos
P2860
P304
P356
10.1093/NDT/GFG034
P407
P50
P577
2003-05-01T00:00:00Z